BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 8138434)

  • 1. The prognostic significance of DNA ploidy in clinically localized prostate cancer treated with radiation therapy.
    Gauwitz MD; Pollack A; el-Naggar AK; Terry NH; von Eschenbach AC; Zagars GK
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):821-8. PubMed ID: 8138434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Near-diploidy: a new prognostic factor for clinically localized prostate cancer treated with external beam radiation therapy.
    Pollack A; Zagars GK; el-Naggar AK; Gauwitz MD; Terry NH
    Cancer; 1994 Apr; 73(7):1895-903. PubMed ID: 7511039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of tumor DNA-ploidy to serum prostate-specific antigen doubling time after radiotherapy for prostate cancer.
    Pollack A; Zagars GK; el-Naggar AK; Terry NH
    Urology; 1994 Nov; 44(5):711-8. PubMed ID: 7526527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship of Ki-67 labeling index to DNA-ploidy, S-phase fraction, and outcome in prostate cancer treated with radiotherapy.
    Khoo VS; Pollack A; Cowen D; Joon DL; Patel N; Terry NH; Zagars GK; von Eschenbach AC; Meistrich ML; Troncoso P
    Prostate; 1999 Nov; 41(3):166-72. PubMed ID: 10517874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deoxyribonucleic acid ploidy and serum prostate specific antigen predict outcome following salvage prostatectomy for radiation refractory prostate cancer.
    Amling CL; Lerner SE; Martin SK; Slezak JM; Blute ML; Zincke H
    J Urol; 1999 Mar; 161(3):857-62; discussion 862-3. PubMed ID: 10022701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA ploidy and survival of patients with clinically localized prostate cancer treated without intent to cure.
    Borre M; Høyer M; Nerstrøm B; Overgaard J
    Prostate; 1998 Sep; 36(4):244-9. PubMed ID: 9719024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of DNA ploidy and adjuvant treatment on progression and survival in patients with pathologic stage T3 (PT3) prostate cancer after radical retropubic prostatectomy.
    Hawkins CA; Bergstralh EJ; Lieber MM; Zincke H
    Urology; 1995 Sep; 46(3):356-64. PubMed ID: 7544934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage D1 prostate cancer treated by radical prostatectomy and adjuvant hormonal treatment. Evidence for favorable survival in patients with DNA diploid tumors.
    Zincke H; Bergstralh EJ; Larson-Keller JJ; Farrow GM; Myers RP; Lieber MM; Barrett DM; Rife CC; Gonchoroff NJ
    Cancer; 1992 Jul; 70(1 Suppl):311-23. PubMed ID: 1600493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma.
    Centeno BA; Zietman AL; Shipley WU; Sobczak ML; Shipley JW; Preffer FI; Boyle BJ; Colvin RB
    Int J Radiat Oncol Biol Phys; 1994 Sep; 30(2):309-15. PubMed ID: 7928459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stage B prostate adenocarcinoma. Flow cytometric nuclear DNA ploidy analysis.
    Montgomery BT; Nativ O; Blute ML; Farrow GM; Myers RP; Zincke H; Therneau TM; Lieber MM
    Arch Surg; 1990 Mar; 125(3):327-31. PubMed ID: 2306181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate-specific antigen and radiation therapy for clinically localized prostate cancer.
    Zagars GK; Pollack A; Kavadi VS; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 May; 32(2):293-306. PubMed ID: 7538498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stage C prostatic adenocarcinoma: flow cytometric nuclear DNA ploidy analysis.
    Nativ O; Winkler HZ; Raz Y; Therneau TM; Farrow GM; Myers RP; Zincke H; Lieber MM
    Mayo Clin Proc; 1989 Aug; 64(8):911-9. PubMed ID: 2796401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.
    Pollack A; Grignon DJ; Heydon KH; Hammond EH; Lawton CA; Mesic JB; Fu KK; Porter AT; Abrams RA; Shipley WU
    J Clin Oncol; 2003 Apr; 21(7):1238-48. PubMed ID: 12663710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of tumor angiogenesis in clinically localized prostate carcinoma treated with external beam radiotherapy.
    Hall MC; Troncoso P; Pollack A; Zhau HY; Zagars GK; Chung LW; von Eschenbach AC
    Urology; 1994 Dec; 44(6):869-75. PubMed ID: 7527168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. External beam radiotherapy dose response of prostate cancer.
    Pollack A; Zagars GK
    Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1011-8. PubMed ID: 9392538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA ploidy and prostate-specific antigen as prognostic factors in clinically resectable prostate cancer.
    Badalament RA; O'Toole RV; Young DC; Drago JR
    Cancer; 1991 Jun; 67(12):3014-23. PubMed ID: 1710533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for T1 and T2 prostate cancer: prostate-specific antigen and disease outcome.
    Zagars GK; Pollack A
    Urology; 1995 Mar; 45(3):476-83. PubMed ID: 7533459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostate specific antigen as an outcome variable for T1 and T2 prostate cancer treated by radiation therapy.
    Zagars GK
    J Urol; 1994 Nov; 152(5 Pt 2):1786-91. PubMed ID: 7523725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In treating localized prostate cancer the efficacy of cryoablation is independent of DNA ploidy type.
    Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
    Technol Cancer Res Treat; 2004 Jun; 3(3):253-7. PubMed ID: 15161318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.